MKI67 and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: In SBS patients with teduglutide treatment, the Ki-67-positive immune staining was increased, as indicated by the percentage of Ki-67-positive epithelial cells (EC) (Figure 3B,D).